Insider Trades
News
globenewswire.comTenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updateglobenewswire.comMay 12
globenewswire.comTenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comMay 8
globenewswire.comTenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officerglobenewswire.comMay 4
globenewswire.comTenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officerglobenewswire.comApr 22
defenseworld.netTenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving Average – What’s Next?defenseworld.netApr 2